eujobs.coEU jobs in brussels
Post a JobHeadhunter

Novartis International AG

General Information

Identification Code: 91269481588-28
Website: [object Object]
Entity Form: Corporation
Registration Category: Companies & groups
Registration Date: 4/27/2009
Last Update: 3/20/2024
EP Accredited Number: 5

Mission & Interests

Goals: Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
  • Borders and security
  • Business and industry
  • Competition
  • Consumers
  • Customs
  • Digital economy and society
  • Economy, finance and the euro
  • Employment and social affairs
  • Environment
  • External relations
  • Institutional affairs
  • International co-operation and development
  • Justice and fundamental rights
  • Public health
  • Regional policy
  • Research and innovation
  • Single market
  • Taxation
  • Trade
Levels of Interest:
  • global

Activities

Main EU Legislative Proposals: Antimicrobial resistance (AMR), ATMP Regulation, Big data, Biosimilars & generics, Clinical Trials Regulation, Data Protection Regulation, EU IP policy, EU Relative Efficacy Assessment (EU REA), EU research policy, EU trade policy, Health Systems Performance Assessment, Health Technology Assessment & Market Access, Industrial policy, IHI, Outcomes-based healthcare systems, Orphan Medicinal Products Regulation, Paediatric Regulation, Patient access to innovation, Patient safety, Pharmaceuticals in the environment, Sustainable Development Goals, CS3D, General Pharmaceutical Legislation (GPL), Critical Medicines Act, EU Mercury Regulation
Communication Activities: European Parliament lunch meeting on health data and rare diseases European Parliament exhibition on heart health European Parliament German speaking round table on IP French speaking stakeholder event on the GPL European Health Summit - session on GPL Expert briefing sessions on Cell and Gene Therapies and rare diseases Publication of Neuroendocrine Tumour Policy Recommendations Communication efforts around radiopharmaceuticals in EU pharmaceutical legislation
Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: Novartis International AGForum 1
Post Code: CH-4002
City: Basel
Country: SWITZERLAND
Phone: [object Object]

EU Office

Address: Rue Belliard 40
City: Brussels
Country: BELGIUM
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: We have calculated the estimate of annual costs related to activities covered by the register by adding our membership fees, event costs, consultancy fees together with facilities (rental charges) and personal costs.

Membership Information

Members10 Percent: 0
Members25 Percent: 7
Members50 Percent: 2
Members75 Percent: 0
Members: 9
Members F T E: 2.75
Info Members: In 2023, 2 associates in the Brussels office spent up to 50% on activities falling within the scope of the register. Seven associates at global and regional headquarters spent up to 25 % of their time on activities falling within the scope of the register. Other associates involved on activities falling within the scope of the register spent less than 10% of their time on such activities.

Structure

Structure Type: Structure
Is Member Of: We do not have members
Organisation Members: British Chamber of Commerce Business Europe Trial membership ECPA EFPIA - Pillar 3 IMI EFPIA (Pillar 1+2) EFPIA: Pillar 3 ICH EFPIA Country engagement EFPIA Campaign mode Eucope (Membership) Eucope Membership - Support to the incentive Steering Group EuropaBio EuropeanIssuers Friends of Europe Kangaroo Medicines for Europe Medicines for Europe Biosimilar Medicines Medicines for Europe VAM Science Business Membership EUMatrix GIRP FH Europe Foundation European Access Academy European Brain Council SMA Alliance on NBS International Patient Organisation for Primary Immunodeficiencies (IPOPI) EUCOPE TRANSFORM EURORDIS EPF 20th Anniversary Policy Event EPF Annual Plan EPF HTA Simulation Project Cancer Patient Europe EFPIA CVD Workstream European Business Summit EUCOPE ECGP Coalition European Alliance for Personalised Medicine Sponsorship Nuclear Medicine Europe (NMEU) European Cancer Organisation (ECO) SPARC European Alliance for Access to Safe Medicines (EAASM) European Kidney Health Alliance (EKHA) International Agency for the Prevention of Blindness (IAPB)